1. Cell Cycle/DNA Damage
    Cytoskeleton
    Metabolic Enzyme/Protease
    Autophagy
  2. Microtubule/Tubulin
    HIF/HIF Prolyl-Hydroxylase
    Autophagy

2-Methoxyestradiol (Synonyms: 2-ME2; NSC-659853)

Cat. No.: HY-12033 Purity: 99.54%
Data Sheet SDS Handling Instructions

2-Methoxyestradiol is a microtubule and HIF-1 inhibitor, binds to tubulin at or near the colchicine site and inhibits the polymerization of tubulin in vitro, works by interfering with normal microtubule function.

For research use only. We do not sell to patients.
2-Methoxyestradiol Chemical Structure

2-Methoxyestradiol Chemical Structure

CAS No. : 362-07-2

Size Price Stock Quantity
Free Sample (0.5-1 mg)   Apply now  
10 mM * 1 mL in DMSO $55 In-stock
10 mg $50 In-stock
50 mg $110 In-stock
100 mg $200 In-stock
200 mg   Get quote  
500 mg   Get quote  

* Please select Quantity before adding items.

    2-Methoxyestradiol purchased from MCE. Usage Cited in: Cancer Biol Ther. 2016 Jun 2;17(6):625-34.

    HL-60 and Kasumi-1 cells are treated with different concentration of 2ME2 (0.1, 0.5, 2.5, or 5μM) for 24 hours or diluent control, and intracelluar protein levels are examined by Western blot.

    2-Methoxyestradiol purchased from MCE. Usage Cited in: Cancer Lett. 2016 Nov 1;382(1):44-52.

    Downregulation of VEGF and HIF-1α by FP08S2 is dependent on Erk inactivation. VEGF and HIF-1α expression at protein level is detected after 2-ME treatment by Western blotting. 18S rRNA is used as internal control in qPCR while GAPDH is used as loading control in Western blotting.

    2-Methoxyestradiol purchased from MCE. Usage Cited in: Exp Ther Med. 14: 1825-1831, 2017.

    HIF 1α regulates the protein levels of RGC 32 and epithelial mesenchymal transition associated genes induced by hypoxia. Proteins are extracted from cells after different treatments. Protein levels of HIF 1α, RGC 32, E cadherin, cytokeratins, N cadherin and vimentin are detected by western blotting. a, no treatment cells under normoxia; b, cells under hypoxia; c, cells are pretreated with HIF 1α inhibitor for 30 min, and then incubated under hypoxia; d, cells are transfected with negative contro
    • Biological Activity

    • Protocol

    • Technical Information

    • Purity & Documentation

    • References

    Description

    2-Methoxyestradiol is a microtubule and HIF-1 inhibitor, binds to tubulin at or near the colchicine site and inhibits the polymerization of tubulin in vitro, works by interfering with normal microtubule function.

    IC50 & Target

    IC50: 1.2 μM (tubulin/microtubule, in living interphase MCF7 cells)[1]

    In Vitro

    2-Methoxyestradiol (5-100 μM) inhibits assembly of purified tubulin in a concentration-dependent manner, with maximal inhibition (60%) at 200 μM 2-Methoxyestradiol (2ME2). However, with microtubule-associated protein-containing microtubules, significantly higher 2-Methoxyestradiol concentrations are required to depolymerize microtubules, and polymer mass is reduced by only 13% at 500 μM 2-Methoxyestradiol. 4 μM 2-Methoxyestradiol reduces the mean growth rate by 17% and dynamicity by 27%. In living interphase MCF7 cells at the IC50 for mitotic arrest (1.2 μM), 2-Methoxyestradiol significantly suppresses the mean microtubule growth rate, duration and length, and the overall dynamicity, consistent with its effects in vitro, and without any observable depolymerization of microtubules. 2-Methoxyestradiol induces G2-M arrest and apoptosis in many actively dividing cell types while sparing quiescent cells. 2-Methoxyestradiol binds to tubulin at or near the colchicine site, it inhibits microtubule assembly, and high concentrations have been shown to depolymerize microtubules in cells. 2-Methoxyestradiol induces G2-M arrest and apoptosis in many actively dividing also blocks mitosis and inhibits endothelial cell migration[1]. 2-Methoxyestradiol (2-ME) decreases the HIF-1α and HIF-2α nuclear staining in cells cultured under hypoxia. The HIF-1α and HIF-2α mRNA levels are significantly lower when cells are exposed to 2-Methoxyestradiol under normoxia and hypoxia. 2-Methoxyestradiol is an anti-angiogenic, anti-proliferative and pro-apoptotic agent that suppresses HIF-1α protein levels and its transcriptional activity. A significant decrease in the growth rate is found in the 10 µM 2-Methoxyestradiol-treated A549 cells in comparison with the DMSO-treated cells (66.2±7.2 and 101.2±2.3%, respectively; p=0.04) at 96 h. 2-Methoxyestradiol at a concentration of 10 µM is used for the apoptosis and HIF-1α and HIF-2α expression assays, due to the significance found for this concentration when cells are incubated under normoxic conditions at 72 h. A significant increase in apoptosis is observed in cells treated with 10 µM 2-Methoxyestradiol in a normoxic condition in comparison with cells under lower O2 concentration (5.8±0.2%; p=0.003)[2].

    In Vivo

    To investigate the effect of 2ME2 on uveitis development, C57BL/6 mice are randomly assigned into two groups and immunized with IRBP peptide. 2ME2 group starts 2-Methoxyestradiol (15 mg/kg) intraperitoneally from day 0 to day 13 while control group is given with vehicle. The disease score of 2-Methoxyestradiol (2ME2) group is 0.30±0.30, significantly lower than that of control group 2.09±0.28 (p<0.05), each group containing 5 mice[3]. Treatment with 2-Methoxyestradiol (60-600 mg/kg/d) results in a dose-dependent inhibition of tumor growth. The percentage of cells with strong pimonidazole-positive staining (+++) is significantly decreased in the 2-Methoxyestradiol-treated group (36.0% for 60 mg/kg/d and 0% for 200 and 600 mg/kg/d) compare with the vehicle-treated group (86.5%). This may be attributed to the dramatic inhibition of tumor growth in a dose-dependent manner following 2-Methoxyestradiol treatment[4].

    Clinical Trial
    NCT Number Sponsor Condition Start Date Phase
    NCT00592579 CASI Pharmaceuticals, Inc. Relapsed Multiple Myeloma|Plateau Phase Multiple Myeloma March 2001 Phase 2
    NCT00028821 National Cancer Institute (NCI) Refractory Multiple Myeloma|Stage III Multiple Myeloma|Unspecified Adult Solid Tumor, Protocol Specific January 2002 Phase 1
    NCT00328497 CASI Pharmaceuticals, Inc. Carcinoid Tumor May 2006 Phase 2
    NCT00030095 National Cancer Institute (NCI) Unspecified Adult Solid Tumor, Protocol Specific September 2001 Phase 1
    NCT00592579 CASI Pharmaceuticals, Inc. Relapsed Multiple Myeloma|Plateau Phase Multiple Myeloma March 2001 Phase 2
    NCT00028821 National Cancer Institute (NCI) Refractory Multiple Myeloma|Stage III Multiple Myeloma|Unspecified Adult Solid Tumor, Protocol Specific January 2002 Phase 1
    NCT00328497 CASI Pharmaceuticals, Inc. Carcinoid Tumor May 2006 Phase 2
    NCT00030095 National Cancer Institute (NCI) Unspecified Adult Solid Tumor, Protocol Specific September 2001 Phase 1
    NCT00592579 CASI Pharmaceuticals, Inc. Relapsed Multiple Myeloma|Plateau Phase Multiple Myeloma March 2001 Phase 2
    NCT00028821 National Cancer Institute (NCI) Refractory Multiple Myeloma|Stage III Multiple Myeloma|Unspecified Adult Solid Tumor, Protocol Specific January 2002 Phase 1
    NCT00328497 CASI Pharmaceuticals, Inc. Carcinoid Tumor May 2006 Phase 2
    NCT00030095 National Cancer Institute (NCI) Unspecified Adult Solid Tumor, Protocol Specific September 2001 Phase 1
    View MoreCollapse
    References
    Preparing Stock Solutions
    Concentration Volume (DMSO) Mass 1 mg 5 mg 10 mg
    1 mM 3.3068 mL 16.5338 mL 33.0677 mL
    5 mM 0.6614 mL 3.3068 mL 6.6135 mL
    10 mM 0.3307 mL 1.6534 mL 3.3068 mL
    Kinase Assay
    [1]

    Microtubule protein (2.75 mg/mL) is assembled to steady-state [in 100 mM PIPES containing 1 mM EGTA and 1 mM MgSO4 (PEM100) and 1 mM GTP, 35°C for 45 minutes] containing 2-Methoxyestradiol (final drug concentrations of 1-500 μM). Final DMSO and ethanol concentrations are adjusted to 1% and 5%, respectively. Concentrations of 2-Methoxyestradiol ≤ 5 μM have no effect on microtubule polymer mass, and thus 20 to 500 μM 2-Methoxyestradiol is used for most of the experiments. Incubation with 2-Methoxyestradiol is carried out for 30 minutes, at which time microtubule depolymerization is maximal, and microtubules are centrifuged at 35°C for 30 minutes and the supernatant is removed from the pellets. Microtubule pellets are solubilized overnight in 0.2 M NaOH and the protein concentrations of supernatants and pellets are determined[1]. MCE has not independently confirmed the accuracy of these methods. They are for reference only.

    Cell Assay
    [1]

    2-Methoxyestradiol (2ME2) is dissolved in DMSO (10 mM) and stored, and then diluted with appropriate media before use[1].

    MCF7 breast carcinoma cells stably transfected with green fluorescent protein (GFP)-α-tubulin are cultured in DMEM supplemented with nonessential amino acids, 0.1% penicillin/streptomycin, 10% fetal bovine serum, and 0.4 mg/mL G418 at 37°C in 5% CO2. Transfection of MCF7 cells with GFP-α-tubulin is carried out. To evaluate mitotic indices, cells are plated at a concentration of 6×104/2 mL into six-well plates. After 48 hours, cells are incubated in the absence or presence of 2-Methoxyestradiol at concentrations ranging from 100 nM to 30 μM for 20 hours. To collect both floating and attached cells, medium is collected; attached cells are rinsed with Versene (137 mM NaCl, 2.7 mM KCl, 1.5 mM KH2PO4, 8.1 mM Na2HPO4, and 0.5 mM EDTA), detached by trypsinization, and added back to the medium. Cells are collected by centrifugation and fixed with 10% formalin for 30 minutes, permeabilized in ice-cold methanol for 10 minutes, and stained with 4′,6-diamidino-2-phenylindole to visualize nuclei. Results are the mean and SE of seven experiments in each of which 500 cells are counted for each concentration. The mitotic IC50 is the drug concentration that induced one half of the maximal mitotic accumulation[1]. MCE has not independently confirmed the accuracy of these methods. They are for reference only.

    Animal Administration
    [3][4]

    2-Methoxyestradiol (2ME2) purchased from MedChem Express is dissolved into DMSO and then diluted[3].

    Mice[3]
    6~8-week-old C57BL/6 mice are used. C57BL/6 mice are immunized subcutaneously 0.1 mL at tail and 0.05 mL at both thigh sites with IRBP antigen complex. 500 ng Pertussis toxin is injected concurrently. This day is settled as day 0. Then mice are divided into 4 groups, each group containing 5 mice. 15 mg/kg 2-Methoxyestradiol or vehicle is abdominal injected during 0-13 days, 0-6 days, and 7-13 days. At day 14 eyes or lymphoglandula is collected after euthanasia.
    Rat[4]
    Fischer 344 rats (average body weight=150 g, n=6 per group) are treated with an i.p. injection of the vehicle (60, 200, or 600 mg/kg/d of 2-Methoxyestradiol/Panzem) for nine consecutive days beginning on the 8th day after the initial tumor cell injection. The experiment is repeated a second time using three rats per group. MCE has not independently confirmed the accuracy of these methods. They are for reference only.

    References
    Molecular Weight

    302.41

    Formula

    C₁₉H₂₆O₃

    CAS No.

    362-07-2

    Storage

    Please store the product under the recommended conditions in the Certificate of Analysis.

    Shipping

    Room temperature in continental US; may vary elsewhere

    Solvent & Solubility

    DMSO: ≥ 36 mg/mL; H2O: < 0.1 mg/mL

    * "<1 mg/mL" means slightly soluble or insoluble. "≥" means soluble, but saturation unknown.

    Purity: 99.54%

    Inquiry Online

    Your information is safe with us. * Required Fields.

    Product name

     

    Salutation

    Applicant name *

     

    Email address *

    Phone number

     

    Organization name *

    Country *

     

    Requested quantity *

    Remarks

    Bulk Inquiry

    Inquiry Information

    Product Name:
    2-Methoxyestradiol
    Cat. No.:
    HY-12033
    Quantity: